Targeting nitric oxide signaling with nNOS inhibitors as a novel strategy for the therapy and prevention of human melanoma

Antioxidants and Redox Signaling

Volumn 19, Issue 5, 2013, Pages 433-447

  Yang, Zhen ^a,b   Misner, Bobbye ^a   Ji, Haitao ^c   Poulos, Thomas L ^d   Silverman, Richard B ^c   Meyskens, Frank L ^a,d,e   Yang, Sun ^a,d,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SHANDONG UNIVERSITY   (China)

^c NORTHWESTERN UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; INTERSTITIAL COLLAGENASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PROTEIN BCL 2; TRANSCRIPTION FACTOR JUND;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; HUMAN; HUMAN CELL; IN VITRO STUDY; MELANOCYTE; MELANOMA; MELANOMA CELL; METASTASIS; PRIORITY JOURNAL; TUMOR INVASION;

ANIMALS; ARGININE; BLOTTING, WESTERN; CELL LINE; CELLS, CULTURED; ENZYME INHIBITORS; HUMANS; MALE; MELANOCYTES; MELANOMA; MICE; MICE, NUDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE I; RNA, SMALL INTERFERING; TUMOR CELLS, CULTURED; ULTRAVIOLET RAYS;

EID: 84879980471     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2012.4563     Document Type: Article

References (61)

1. Ahmad N, Srivastava RC, Agarwal R, and Mukhtar H. Nitric oxide synthase and skin tumor promotion. Biochem Biophys Res Commun 232: 328-331, 1997
2. Ahmed B, and Van Den Oord JJ. Expression of the neuronal isoform of nitric oxide synthase (nNOS) and its inhibitor, protein inhibitor of nNOS, in pigment cell lesions of the skin. Br J Dermatol 141: 12-19, 1999
3. Ahmed B, and Van Den Oord JJ. Expression of the inducible isoform of nitric oxide synthase in pigment cell lesions of the skin. Br J Dermatol 142: 432-440, 2000
4. Autier P, Dore JF, Eggermont AMM, and Coebergh JW. Epidemiological evidence that UVA radiation is involved in the genesis of cutaneous melanoma. Curr Opin Oncol 23: 189-196, 2011
5. Berking C, Takemoto R, Satyamoorthy K, Elenitsas R, and Herlyn M. Basic fibroblast growth factor and ultraviolet B transform melanocytes in human skin. Am J Pathol 158: 943-953, 2001
6. Burnett ME, and Wang SQ. Current sunscreen controversies: A critical review. Photodermatol Photoimmunol Photomed 27: 58-67, 2011
7. Chung CY, Madhunapantula SV, Desai D, Amin S, and Robertson GP. Melanoma prevention using topical PBISe. Cancer Prev Res (Phila) 4: 935-948, 2011
8. Cichocki M, Blumczynska J, and Baer-Dubowska W. Naturally occurring phenolic acids inhibit 12-Otetradecanoylphorbol-13-acetate induced NF-kappaB, iNOS and COX-2 activation in mouse epidermis. Toxicology 268: 118-124, 2010
9. Crane BR, Arvai AS, Gachhui R, Wu C, Ghosh DK, Getzoff ED, Stuehr DJ, and Tainer JA. The structure of nitric oxide synthase oxygenase domain and inhibitor complexes. Science 278: 425-431, 1997
10. De Fabo EC, Noonan FP, Fears T, and Merlino G. Ultraviolet B but not ultraviolet A radiation initiates melanoma. Cancer Res 64: 6372-6376, 2004
11. Delker SL, Ji H, Li H, Jamal J, Fang J, Xue F, Silverman RB, and Poulos TL. Unexpected binding modes of nitric oxide synthase inhibitors effective in the prevention of a cerebral palsy phenotype in an animal model. J Am Chem Soc 132: 5437-5442, 2010
12. Dupin E, and Le Douarin NM. Development of melanocyte precursors from the vertebrate neural crest. Oncogene 22: 3016-3023, 2003
13. Ekmekcioglu S, Ellerhorst JA, Prieto VG, Johnson MM, Broemeling LD, and Grimm EA. Tumor iNOS predicts poor survival for stage III melanoma patients. Int J Cancer 119: 861-866, 2006
14. This reference has been deleted
15. Gonzalez Maglio DH, Paz ML, Ferrari A, Weill FS, Czerniczyniec A, Leoni J, and Bustamante J. Skin damage and mitochondrial dysfunction after acute ultraviolet B irradiation: Relationship with nitric oxide production. Photodermatol Photoimmunol Photomed 21: 311-317, 2005
16. Grimm EA, Ellerhorst J, Tang CH, and Ekmekcioglu S. Constitutive intracellular production of iNOS and NO in human melanoma: Possible role in regulation of growth and resistance to apoptosis. Nitric Oxide 19: 133-137, 2008
17. This reference has been deleted
18. This reference has been deleted
19. Heller A. The need for monitoring the actual nitric oxide concentration in tumors. Bioanal Rev 1: 3-6, 2009
20. Herlyn M, Hsu MY, Meier FE, Nesbit M, Hsu JY, Van Belle P, and Elder DE. E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and downregulates expression of invasion-related adhesion receptors. Am J Pathol 156: 1515-1525, 2000
21. Ji H, Delker SL, Li H, Martasek P, Roman LJ, Poulos TL, and Silverman RB. Exploration of the active site of neuronal nitric oxide synthase by the design and synthesis of pyrrolidinomethyl 2-aminopyridine derivatives. J Med Chem 53: 7804-7824, 2010
22. Ji H, Li H, Martasek P, Roman LJ, Poulos TL, and Silverman RB. Discovery of highly potent and selective inhibitors of neuronal nitric oxide synthase by fragment hopping. J Med Chem 52: 779-797, 2009
23. Ji H, Tan S, Igarashi J, Li H, Derrick M, Martasek P, Roman LJ, Vasquez-Vivar J, Poulos TL, and Silverman RB. Selective neuronal nitric oxide synthase inhibitors and the prevention of cerebral palsy. Ann Neurol 65: 209-217, 2009
24. Johansson CC, Egyhazi S,Masucci G, Harlin H,Mougiakakos D, Poschke I, Nilsson B, Garberg L, Tuominen R, Linden D, Stolt MF, Hansson J, and Kiessling R. Prognostic significance of tumor iNOS and COX-2 in stage III malignant cutaneous melanoma. Cancer Immunol Immunother 58: 1085-1094, 2009
25. Joshi M, and White WL. A radial growth phase human melanoma cell line and tumorigenic variants of the same cell line differentially express neuronal nitric oxide synthase. J Invest Dermatol 106: 290-290, 1996
26. Knowles RG, and Moncada S. Nitric oxide synthases in mammals. Biochem J 298 (Pt 2): 249-258, 1994
27. Leung EL, Fraser M, Fiscus RR, and Tsang BK. Cisplatin alters nitric oxide synthase levels in human ovarian cancer cells: Involvement in p53 regulation and cisplatin resistance. Br J Cancer 98: 1803-1809, 2008
28. Li C, Hu Z, Liu Z, Wang LE, Gershenwald JE, Lee JE, Prieto VG, Duvic M, Grimm EA, and Wei Q. Polymorphisms of the neuronal and inducible nitric oxide synthase genes and the risk of cutaneous melanoma: A case-control study. Cancer 109: 1570-1578, 2007
29. Liebmann J, Kolb-Bachofen V, Mahotka C, and Suschek CV. Photolytically generated nitric oxide inhibits caspase activity and results in AIF-mediated cell death. J Mol Med 88: 279-287, 2010
30. Lin JK, and Lin-Shiau SY. Mechanisms of cancer chemoprevention by curcumin. Proc Natl Sci Counc Repub China B 25: 59-66, 2001
31. Liu W, and Wu S. Differential roles of nitric oxide synthases in regulation of ultraviolet B light-induced apoptosis. Nitric Oxide 23: 199-205, 2010
32. Madhunapantula SV, Desai D, Sharma A, Huh SJ, Amin S, and Robertson GP. PBISe, a novel selenium-containing drug for the treatment of malignant melanoma. Mol Cancer Ther 7: 1297-1308, 2008
33. Maksimovic-Ivanic D, Mijatovic S, Harhaji L, Miljkovic D, Dabideen D, Fan Cheng K, Mangano K, Malaponte G, Al-Abed Y, Libra M, Garotta G, Nicoletti F, and Stosic-Grujicic S. Anticancer properties of the novel nitric oxide-donating compound (S,R)-3-phenyl-4,5-dihydro-5-isoxazole acetic acid-nitric oxide in vitro and in vivo. Mol Cancer Ther 7: 510-520, 2008
34. Martinez-Ruiz A, Cadenas S, and Lamas S. Nitric oxide signaling: Classical, less classical, and nonclassical mechanisms. Free Radic Biol Med 51: 17-29, 2011
35. Massi D, De Nisi MC, Franchi A, Mourmouras V, Baroni G, Panelos J, Santucci M, and Miracco C. Inducible nitric oxide synthase expression in melanoma: Implications in lymphangiogenesis. Mod Pathol 22: 21-30, 2009
36. This reference has been deleted
37. This reference has been deleted
38. Menter J, Nokkaew C, Sprewell A, Eatman D, and Harris-Hooker S. Pigment melanin mediates a redox reaction between adsorbed nitric oxide and O-2 in vitro. Pigment Cell Melanoma Res 24: 794-794, 2011
39. Meyskens FL, Jr., and Berwick M. UV or not UV: Metals are the answer. Cancer Epidemiol Biomarkers Prev 17: 268-270, 2008
40. Mitchell D, Paniker L, Sanchez G, Trono D, and Nairn R. The etiology of sunlight-induced melanoma in Xiphophorus hybrid fish. Mol Carcinog 46: 679-684, 2007
41. Mitchell DL, Fernandez AA, Nairn RS, Garcia R, Paniker L, Trono D, Thames HD, and Gimenez-Conti I. Ultraviolet A does not induce melanomas in a Xiphophorus hybrid fish model. Proc Natl Acad Sci U S A 107: 9329-9334, 2010
42. Moore WM, Webber RK, Jerome GM, Tjoeng FS, Misko TP, and Currie MG. L-N6-(1-iminoethyl)lysine: A selective inhibitor of inducible nitric oxide synthase. J Med Chem 37: 3886-3888, 1994
43. Noonan FP, Otsuka T, Bang S, Anver MR, and Merlino G. Accelerated ultraviolet radiation-induced carcinogenesis in hepatocyte growth factor/scatter factor transgenic mice. Cancer Res 60: 3738-3743, 2000
44. Ohshima H, Sawa T, and Akaike T. 8-Nitroguanine, a product of nitrative DNA damage caused by reactive nitrogen species: Formation, occurrence, and implications in inflammation and carcinogenesis. Antioxid Redox Signal 8: 1033-1045, 2006
45. Oliveira CJ, Curcio MF, Moraes MS, Tsujita M, Travassos LR, Stern A, and Monteiro HP. The low molecular weight Snitrosothiol, S-nitroso-N- acetylpenicillamine, promotes cell cycle progression in rabbit aortic endothelial cells. Nitric Oxide 18: 241-255, 2008
46. Patel JB, Shah FD, Shukla SN, Shah PM, and Patel PS. Role of nitric oxide and antioxidant enzymes in the pathogenesis of oral cancer. J Cancer Res Ther 5: 247-253, 2009
47. Romero-Graillet C, Aberdam E, Clement M, Ortonne JP, and Ballotti R. Nitric oxide produced by ultraviolet-irradiated keratinocytes stimulates melanogenesis. J Clin Invest 99: 635-642, 1997
48. Russo PA, and Halliday GM. Inhibition of nitric oxide and reactive oxygen species production improves the ability of a sunscreen to protect from sunburn, immunosuppression and photocarcinogenesis. Br J Dermatol 155: 408-415, 2006
49. Savaraj N, YouM,Wu C,WangpaichitrM, KuoMT, and Feun LG. Arginine deprivation, autophagy, apoptosis (AAA) for the treatment of melanoma. Curr Mol Med 10: 405-412, 2010
50. Siegel R, Desantis C, Virgo K, Stein K, Mariotto A, Smith T, Cooper D, Gansler T, Lerro C, Fedewa S, Lin C, Leach C, Cannady RS, Cho H, Scoppa S, Hachey M, Kirch R, Jemal A, and Ward E. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin 62: 220-241, 2012
51. Sikora AG, Gelbard A, Davies MA, Sano D, Ekmekcioglu S, Kwon J, Hailemichael Y, Jayaraman P, Myers JN, Grimm EA, and Overwijk WW. Targeted inhibition of inducible nitric oxide synthase inhibits growth of human melanoma in vivo and synergizes with chemotherapy. Clin Cancer Res 16: 1834-1844, 2010
52. Silverman RB. Design of selective neuronal nitric oxide synthase inhibitors for the prevention and treatment of neurodegenerative diseases. Acc Chem Res 42: 439-451, 2009
53. Szekeres T, Saiko P, Fritzer-Szekeres M, Djavan B, and Jager W. Chemopreventive effects of resveratrol and resveratrol derivatives. Ann N Y Acad Sci 1215: 89-95, 2011
54. Tew KD, Manevich Y, Grek C, Xiong Y, Uys J, and Townsend DM. The role of glutathione S-transferase P in signaling pathways and S-glutathionylation in cancer. Free Radic Biol Med 51: 299-313, 2011
55. Thomas DD, Ridnour LA, Isenberg JS, Flores-Santana W, Switzer CH, Donzelli S, Hussain P, Vecoli C, Paolocci N, Ambs S, Colton CA, Harris CC, Roberts DD, and Wink DA. The chemical biology of nitric oxide: Implications in cellular signaling. Free Radic Biol Med 45: 18-31, 2008
56. Tschugguel W, Pustelnik T, Lass H, Mildner M, Weninger W, Schneeberger C, Jansen B, Tschachler E, Waldhor T, Huber JC, and Pehamberger H. Inducible nitric oxide synthase (iNOS) expression may predict distant metastasis in human melanoma. Br J Cancer 79: 1609-1612, 1999
57. Yang S, Irani K, Heffron SE, Jurnak F, and Meyskens FL, Jr. Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE/Ref-1) in human melanoma and identification of the therapeutic potential of resveratrol as an APE/Ref-1 inhibitor. Mol Cancer Ther 4: 1923-1935, 2005
58. Yang S, McNulty S, and Meyskens FL, Jr. During human melanoma progression AP-1 binding pairs are altered with loss of c-Jun in vitro. Pigment Cell Res 17: 74-83, 2004
59. Yang S, Misner BJ, Chiu RJ, and Meyskens FL, Jr. Redox effector factor-1, combined with reactive oxygen species, plays an important role in the transformation of JB6 cells. Carcinogenesis 28: 2382-2390, 2007
60. Yang TS, Lu SN, Chao Y, Sheen IS, Lin CC, Wang TE, Chen SC,Wang JH, Liao LY, Thomson JA,Wang-Peng J, Chen PJ, and Chen LT. A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients. Br J Cancer 103: 954-960, 2010
61. Yang Z, Yang S, Misner BJ, Chiu R, Liu F, and Meyskens FL, Jr. Nitric oxide initiates progression of human melanoma via a feedback loop mediated by apurinic/apyrimidinic endonuclease-1/redox factor-1, which is inhibited by resveratrol. Mol Cancer Ther 7: 3751-3760, 2008